News

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.
I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and world-changing—that ...
Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.
As drug development increasingly targets multiple indications, pharma companies must make strategic branding ...
Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by rising obesity and type 2 diabetes incidences, the ...
While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Due to popularity of the medications, GLP-1s were in short supply up until recently. Obesity is a common issue among ...